°Ë»ö
ä¿ë
Á¤º¸
    °­¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ
    ±â»çÀÔ·Â : 23.02.22 14:42:58
    1 °¡
    ÇÃÄ£Ãß°¡

    ¾ÆÁÖ´ëÇб³·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§ ¼ö¿©




    [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] °­¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥°¡ ¾ÆÁÖ´ë·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇß´Ù. °­ ´ëÇ¥´Â Çѱ¹À¯³ªÀÌƼµåÁ¦¾à â¾÷ÁÖ °­´ö¿µ ´ëÇ¥ Àå³²ÀÌ´Ù.

    °­ ´ëÇ¥´Â 22ÀÏ ¾ÆÁÖ´ëÇб³¿¡¼­ ¿­¸° 2022Çг⵵ Àü±â ¾àÇдëÇÐ ÇÐÀ§¼ö¿©½Ä¿¡¼­ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ¼ö¿©¹Þ¾Ò´Ù. °­ ´ëÇ¥´Â "¾ÕÀ¸·Î Çѱ¹À¯³ªÀÌƼµåÁ¦¾àÀÇ ¹ßÀü¿¡ ´õ Å©°Ô ±â¿©ÇÏ°Ú´Ù"°í ¸»Çß´Ù.
    À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com)
    ±ÛÀÚÅ©±â ¼³Á¤
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    • ÀǾàÇ° µµ¸Å»ó KGSPÇ°Áú°ü¸®¾à»ç´Ô ¸ðÁý ¹Ù·Î°¡±â
    • ¼­¿ïÁö¹æ±³Á¤Ã» ÀϹÝÁ÷°ø¹«¿ø(¾à¹«ÁÖ»ç) °æ·Â°æÀïä¿ë½ÃÇè °ø°í ¹Ù·Î°¡±â
    • R&DºÎ¼­ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼­¿ïÁö»ç) ¹Ù·Î°¡±â
    • Medical Information Associate ¹Ù·Î°¡±â
    • Áö¿¤Æĸ¶ °³¹ßº»ºÎ_»ç¾÷°³¹ßÆÀ, °³¹ßÆÀ ä¿ë °ø°í ¹Ù·Î°¡±â
    • [Çѵ¶] MI ¸Å´ÏÀú/°Ç°­±â´É½ÄÇ° ¿¬±¸¿ø/¸¶ÄÉÆÃ/µðÁöÅÐÇコÄÉ¾î ¿µ¾÷/IVD ¿µ¾÷/RA/Corporate Development/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç ¹Ù·Î°¡±â
    • ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â
    • °Ç°­±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â
    • Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼­ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â
    • ¾ÆÁÖ´ë
      ¤»
      µÎ ±³¼ö´Ô..
      ȸÀå´Ô Á¹¾÷»çÁøÀε¥ Á» ´ÙÁ¤ÇÏ°Ô Æ÷Áî ÃëÇϽÃÁö..
      23.02.22 22:41:21
      0 ¼öÁ¤ »èÁ¦ 0 0
    0/300
     
    ¸ÞÀϺ¸³»±â
    ±â»çÁ¦¸ñ : °­¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ